Advancing a Public Health-Promoting National Opioid Policy
An American public health and safety-promoting drug policy agenda grounded in sound science is long overdue.
substance use disorder
-
Read more: Advancing a Public Health-Promoting National Opioid Policy -
Read more: Bold Steps Needed to Correct Course in US Drug Policies Bold Steps Needed to Correct Course in US Drug Policies
Moving the United States beyond the opioid overdose crisis and pernicious inequities in law enforcement requires bold, innovative solutions.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of February 2021.
-
Read more: Incidental Findings in Deep Phenotyping Research: Legal and Ethical Considerations Incidental Findings in Deep Phenotyping Research: Legal and Ethical Considerations
What obligations do researchers have to disclose potentially life-altering incidental findings as they happen in real time?
-
Read more: TWIHL 212: Substance Use Privacy Before and After CARES TWIHL 212: Substance Use Privacy Before and After CARES
The Week in Health Law Podcast from Nicolas Terry is a commuting-length discussion about some of the more thorny issues in health law and policy.
-
Read more: Protecting the Vulnerable Substance Use Disorder Population During COVID-19 Protecting the Vulnerable Substance Use Disorder Population During COVID-19
By Brandon George and Nicolas P. Terry Introduction Earlier this month, Dr. Nora Volkow, director of the National Institute on Drug Abuse identified those with substance use disorder (SUD) as a particularly vulnerable population during the COVID-19 pandemic. She highlighted the negative effects of opioid or methamphetamine use on respiratory and pulmonary health in addition…
